High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
01 2020
Historique:
received: 13 07 2019
accepted: 19 11 2019
pubmed: 8 1 2020
medline: 14 4 2020
entrez: 8 1 2020
Statut: ppublish

Résumé

The intestinal microbiota is a complex community of bacteria, archaea, viruses, protists and fungi

Identifiants

pubmed: 31907459
doi: 10.1038/s41591-019-0709-7
pii: 10.1038/s41591-019-0709-7
pmc: PMC7005909
mid: NIHMS1544100
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-64

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI139632
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI093808
Pays : United States
Organisme : NHLBI NIH HHS
ID : K08 HL143189
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI137269
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI093808
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA228308
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Paterson, M. J., Oh, S. & Underhill, D. M. Host–microbe interactions: commensal fungi in the gut. Curr. Opin. Microbiol. 40, 131–137 (2017).
pubmed: 29175338 pmcid: 29175338
Richard, M. L. & Sokol, H. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases. Nat. Rev. Gastroenterol. Hepatol. 16, 331–345 (2019).
pubmed: 30824884 pmcid: 30824884
Blander, J. M., Longman, R. S., Iliev, I. D., Sonnenberg, G. F. & Artis, D. Regulation of inflammation by microbiota interactions with the host. Nat. Immunol. 18, 851–860 (2017).
pubmed: 28722709 pmcid: 28722709
Koh, A. Y. The microbiome in hematopoietic stem cell transplant recipients and cancer patients: opportunities for clinical advances that reduce infection. PLoS Pathog. 13, e1006342 (2017).
pubmed: 28662165 pmcid: 28662165
Lewis, B. B. & Pamer, E. G. Microbiota-based therapies for Clostridium difficile and antibiotic-resistant enteric infections. Annu. Rev. Microbiol. 71, 157–178 (2017).
pubmed: 28617651 pmcid: 28617651
Keith, J. W. & Pamer, E. G. Enlisting commensal microbes to resist antibiotic-resistant pathogens. J. Exp. Med. 216, 10–19 (2019).
pubmed: 30309968 pmcid: 30309968
Kim, S. G. et al. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. Nature 572, 665–669 (2019).
pubmed: 31435014 pmcid: 31435014
Underhill, D. M. & Iliev, I. D. The mycobiota: interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 14, 405–416 (2014).
pubmed: 24854590 pmcid: 24854590
Nucci, M. & Anaissie, E. Revisiting the source of candidemia: skin or gut? Clin. Infect. Dis. 33, 1959–1967 (2001).
pubmed: 11702290 pmcid: 11702290
Cesaro, S. et al. Incidence, risk factors, and long-term outcome of acute leukemia patients with early candidemia after allogeneic stem cell transplantation: a study by the acute leukemia and infectious diseases working parties of European Society for Blood and Marrow Transplantation. Clin. Infect. Dis. 67, 564–572 (2018).
pubmed: 29481599 pmcid: 29481599
Kohler, J. R., Casadevall, A. & Perfect, J. The spectrum of fungi that infects humans. Cold Spring Harb. Perspect. Med. 5, a019273 (2014).
pubmed: 25367975 pmcid: 25367975
Weiner, L. M. et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect. Control Hosp. Epidemiol. 37, 1288–1301 (2016).
pubmed: 27573805 pmcid: 27573805
Snyder, G. M. & Wright, S. B. The epidemiology and prevention of Candida auris. Curr. Infect. Dis. Rep. 21, 19 (2019).
pubmed: 31044272 pmcid: 31044272
Slavin, M. A. et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: a prospective, randomized, double-blind study. J. Infect. Dis. 171, 1545–1552 (1995).
pubmed: 7769290 pmcid: 7769290
Goodman, J. L. et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. 326, 845–851 (1992).
pubmed: 1542320 pmcid: 1542320
Ubeda, C. et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 120, 4332–4341 (2010).
pubmed: 21099116 pmcid: 21099116
Tamburini, F. B. et al. Precision identification of diverse bloodstream pathogens in the gut microbiome. Nat. Med. 24, 1809–1814 (2018).
pubmed: 30323331 pmcid: 30323331
Taur, Y. et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 55, 905–914 (2012).
pubmed: 22718773 pmcid: 22718773
Lee, Y. J. et al. Protective factors in the intestinal microbiome against Clostridium difficile infection in recipients of allogeneic hematopoietic stem cell transplantation. J. Infect. Dis. 215, 1117–1123 (2017).
pubmed: 28498996 pmcid: 28498996
Taur, Y. et al. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci. Transl. Med. 10, eaap9489 (2018).
pubmed: 6468978 pmcid: 6468978
Sipsas, N. V. et al. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001–2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115, 4745–4752 (2009).
Wang, E. et al. The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. J. Antimicrob. Chemother. 70, 2362–2368 (2015).
pubmed: 6366596 pmcid: 6366596
Forrest, G. N., Weekes, E. & Johnson, J. K. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J. Infect. 56, 126–129 (2008).
Nash, A. K. et al. The gut mycobiome of the human microbiome project healthy cohort. Microbiome 5, 153 (2017).
pubmed: 5702186 pmcid: 5702186
Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537–7541 (2009).
pubmed: 2786419 pmcid: 2786419
Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335–336 (2010).
pubmed: 3156573 pmcid: 3156573
Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996–998 (2013).
Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).
pubmed: 27214047 pmcid: 27214047
Dubin, K. A. et al. Diversification and evolution of vancomycin-resistant Enterococcus faecium during intestinal domination. Infect. Immun. 87, e00102-19 (2019).
Butler, G. et al. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459, 657–662 (2009).
pubmed: 19465905 pmcid: 19465905
Pryszcz, L. P., Nemeth, T., Gacser, A. & Gabaldon, T. Unexpected genomic variability in clinical and environmental strains of the pathogenic yeast Candida parapsilosis. Genome Biol. Evol. 5, 2382–2392 (2013).
pubmed: 24259314 pmcid: 24259314
Pryszcz, L. P. et al. The genomic aftermath of hybridization in the opportunistic pathogen Candida metapsilosis. PLoS Genet. 11, e1005626 (2015).
pubmed: 26517373 pmcid: 26517373
Schroder, M. S. et al. Multiple origins of the pathogenic yeast Candida orthopsilosis by separate hybridizations between two parental species. PLoS Genet. 12, e1006404 (2016).
pubmed: 27806045 pmcid: 27806045
Branco, J. et al. Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and NDT80 in Candida parapsilosis azole resistance. Clin. Microbiol. Infect. 23, 575 e571–575 e578 (2017).
Rybak, J. M. et al. Loss of C-5 sterol desaturase activity results in increased resistance to azole and echinocandin antifungals in a clinical isolate of Candida parapsilosis. Antimicrob. Agents Chemother. 61, e00651-17 (2017).
Whaley, S. G. et al. The RTA3 gene, encoding a putative lipid translocase, influences the susceptibility of Candida albicans to fluconazole. Antimicrob. Agents Chemother. 60, 6060–6066 (2016).
pubmed: 5038240 pmcid: 5038240
Srivastava, A. et al. Distinct roles of the 7-transmembrane receptor protein Rta3 in regulating the asymmetric distribution of phosphatidylcholine across the plasma membrane and biofilm formation in Candida albicans. Cell Microbiol. 19, e12767 (2017).
Fan, D. et al. Activation of HIF-1alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat. Med. 21, 808–814 (2015).
pubmed: 4496259 pmcid: 4496259
Taur, Y. Intestinal microbiome changes and stem cell transplantation: lessons learned. Virulence 7, 930–938 (2016).
pubmed: 5160401 pmcid: 5160401
Zhao, J., Murray, S. & Lipuma, J. J. Modeling the impact of antibiotic exposure on human microbiota. Sci. Rep. 4, 4345 (2014).
pubmed: 24614401 pmcid: 24614401
del Pilar Vercher, M. et al. Differentiation of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis by specific PCR amplification of the RPS0 intron. Int. J. Med. Microbiol. 301, 531–535 (2011).
pubmed: 21570908 pmcid: 21570908
Liu, C. M. et al. FungiQuant: a broad-coverage fungal quantitative real-time PCR assay. BMC Microbiol. 12, 255 (2012).
pubmed: 23136846 pmcid: 23136846
White, P. L., Shetty, A. & Barnes, R. A. Detection of seven Candida species using the Light-Cycler system. J. Med. Microbiol. 52, 229–238 (2003).
pubmed: 12621088 pmcid: 12621088
Haak, B. W. et al. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood 131, 2978–2986 (2018).
pubmed: 29674425 pmcid: 29674425
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).
pubmed: 2231712 pmcid: 2231712
Tatusova, T. et al. Update on RefSeq microbial genomes resources. Nucleic Acids Res. 43, D599–D605 (2015).
pubmed: 25510495 pmcid: 25510495
McMurdie, P. J. & Holmes, S. Phyloseq: a bioconductor package for handling and analysis of high-throughput phylogenetic sequence data. Pac. Symp. Biocomput. 2012, 235–246 (2011).
Turner, S. A. & Butler, G. The Candida pathogenic species complex. Cold Spring Harb. Perspect. Med. 4, a019778 (2014).
pubmed: 25183855 pmcid: 25183855
Riccombeni, A., Vidanes, G., Proux-Wera, E., Wolfe, K. H. & Butler, G. Sequence and analysis of the genome of the pathogenic yeast Candida orthopsilosis. PLoS ONE 7, e35750 (2012).
pubmed: 22563396 pmcid: 22563396
McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
pubmed: 2928508 pmcid: 2928508
Lischer, H. E., Excoffier, L. & Heckel, G. Ignoring heterozygous sites biases phylogenomic estimates of divergence times: implications for the evolutionary history of microtus voles. Mol. Biol. Evol. 31, 817–831 (2014).
Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312–1313 (2014).
pubmed: 24451623 pmcid: 24451623
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
pubmed: 20110278 pmcid: 20110278
Smit, A., Hubley, R. & Green, P. RepeatMasker Open-4.0. 2013–2015, http://www.repeatmasker.org (2015).
Benson, G. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res. 27, 573–580 (1999).
pubmed: 9862982 pmcid: 9862982

Auteurs

Bing Zhai (B)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Mihaela Ola (M)

School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.

Thierry Rolling (T)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Division of Infectious Diseases, First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Nicholas L Tosini (NL)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Sari Joshowitz (S)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Eric R Littmann (ER)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Luigi A Amoretti (LA)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Emily Fontana (E)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Roberta J Wright (RJ)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Edwin Miranda (E)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Charlotte A Veelken (CA)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Sejal M Morjaria (SM)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Weill Cornell Medical College, New York, NY, USA.

Jonathan U Peled (JU)

Weill Cornell Medical College, New York, NY, USA.
Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Marcel R M van den Brink (MRM)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Weill Cornell Medical College, New York, NY, USA.
Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

N Esther Babady (NE)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Geraldine Butler (G)

School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.

Ying Taur (Y)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taury@mskcc.org.
Weill Cornell Medical College, New York, NY, USA. taury@mskcc.org.

Tobias M Hohl (TM)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hohlt@mskcc.org.
Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hohlt@mskcc.org.
Weill Cornell Medical College, New York, NY, USA. hohlt@mskcc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH